7Baggers
 FibroGen, Inc. (NASDAQ:FGEN) Q3 2025 Earnings Call Transcript  Insider Monkey Wed, 12 Nov 2025 13:26:50 GMT
 FibroGen’s Strategic Moves and Financial Highlights  TipRanks Tue, 11 Nov 2025 04:09:56 GMT
 FibroGen: Q3 Earnings Snapshot  Stamford Advocate Tue, 11 Nov 2025 03:54:23 GMT
 fibrogen (fgen) reports q3 loss, lags revenue estimates  sharewise.com Tue, 11 Nov 2025 01:45:24 GMT
 FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates  Yahoo Finance Mon, 10 Nov 2025 23:00:01 GMT
 earnings call transcript: fibrogen q3 2025 sees revenue rise, cost cuts  Investing.com UK Mon, 10 Nov 2025 22:54:00 GMT
 FibroGen: Q3 Earnings Snapshot  San Francisco Chronicle Mon, 10 Nov 2025 22:29:26 GMT
 FibroGen (FGEN) Q3 Revenue Falls Short, Advances Key Trials  GuruFocus Mon, 10 Nov 2025 21:37:05 GMT
 FibroGen Sells China Unit To AstraZeneca And Refocuses  Finimize Mon, 10 Nov 2025 21:26:40 GMT
 FibroGen reports Q3 EPS ($3.25), consensus ($4.01)  TipRanks Mon, 10 Nov 2025 08:00:00 GMT
 FibroGen Receives $6.4 Million Payment from AstraZeneca  The Globe and Mail Fri, 07 Nov 2025 21:46:36 GMT
 FibroGen Receives $6.4 Million Payment from AstraZeneca  TipRanks Thu, 06 Nov 2025 21:40:30 GMT
 FibroGen Receives Payment from AstraZeneca  TradingView Thu, 06 Nov 2025 21:15:00 GMT
 FibroGen to Report Third Quarter 2025 Financial Results  GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT

FibroGen, Inc
(NASDAQ:FGEN) 

FGEN stock logo

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for...

Full Time Employees: 531
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends